Monica Rodolfo Selected Research

Monica Rodolfo Research Topics

Disease

46	Melanoma (Melanoma, Malignant) 01/2024 - 06/2004
33	Neoplasms (Cancer) 01/2024 - 07/2002
6	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2002
2	Disease Progression 01/2024 - 11/2022
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2015
2	Adenocarcinoma 08/2009 - 11/2002
2	Wilms Tumor (Wilm's Tumor) 01/2009 - 02/2008
2	Neuroblastoma 01/2008 - 10/2003
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Starvation 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Skin Neoplasms (Skin Cancer) 10/2020
1	Adenocarcinoma of Lung 12/2019
1	Hematologic Neoplasms (Hematological Malignancy) 03/2016
1	Carcinogenesis 10/2014
1	Nevus (Nevi) 05/2014
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 05/2014
1	Astrocytoma (Pilocytic Astrocytoma) 05/2014
1	Lymphatic Metastasis 08/2010

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2007
8	VemurafenibIBA 01/2024 - 12/2011
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2016
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 11/2019
6	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2010
5	Immune Checkpoint InhibitorsIBA 01/2024 - 12/2018
5	EnzymesIBA 01/2022 - 10/2003
4	Phosphotransferases (Kinase)IBA 01/2024 - 01/2015
4	CytokinesIBA 01/2016 - 01/2009
3	Drug CombinationsIBA 11/2022 - 06/2014
3	CholesterolIBA 01/2022 - 06/2005
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2016
2	LipidsIBA 01/2024 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 01/2022
2	AntibodiesIBA 01/2024 - 10/2003
2	trametinibIBA 01/2024 - 11/2022
2	Peptides (Polypeptides)IBA 01/2023 - 10/2003
2	Ribonucleases (Ribonuclease)IBA 10/2022 - 01/2017
2	ORALIT (ORS)IBA 01/2019 - 12/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2009
2	Small Interfering RNA (siRNA)IBA 12/2011 - 07/2006
2	AntigensIBA 07/2006 - 10/2003
1	Oleic Acid (Oleate)IBA 01/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024
1	IpilimumabIBA 01/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	KisspeptinsIBA 01/2023
1	Kisspeptin-1 ReceptorsIBA 01/2023
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2022
1	dabrafenibIBA 11/2022
1	2-5A-dependent ribonuclease (RNase L)IBA 10/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2022
1	Testosterone (Sustanon)FDA Link 10/2022
1	Hormones (Hormone)IBA 10/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2022
1	AndrogensIBA 10/2022
1	Proto-Oncogene Proteins B-rafIBA 01/2022
1	avasimibeIBA 01/2022
1	Orlistat (Xenical)FDA Link 05/2021
1	Polycomb Repressive Complex 2IBA 10/2020
1	nutlin 3IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	CateninsIBA 11/2019
1	Type 1 Melanocortin ReceptorIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2016
1	honokiolIBA 03/2016
1	Oxygen (Dioxygen)IBA 03/2016
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 03/2016
1	1-methyl-1-piperidinomethane sulfonateIBA 02/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2016
1	Microphthalmia-Associated Transcription FactorIBA 02/2016
1	TrabectedinIBA 01/2015
1	ProstaglandinsIBA 10/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2014
1	Dinoprostone (PGE2)FDA Link 10/2014
1	Ligases (Synthetase)IBA 10/2014
1	Interleukin-6 (Interleukin 6)IBA 07/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2014
1	LigandsIBA 06/2014
1	Histone Deacetylase InhibitorsIBA 06/2014
1	Temozolomide (Temodar)FDA LinkGeneric 06/2014
1	CC ChemokinesIBA 06/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2014
1	ChemokinesIBA 06/2014
1	Dihydrotachysterol (AT 10)IBA 05/2014
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2012
1	Proton Pump InhibitorsIBA 07/2010
1	Antineoplastic Agents (Antineoplastics)IBA 07/2010
1	CaspasesIBA 07/2010
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2009

Therapy/Procedure

16	Therapeutics 01/2024 - 10/2003
7	Immunotherapy 01/2024 - 07/2014
2	Ligation 05/2014 - 11/2009
1	Bioreactors (Bioreactor) 01/2022
1	Duration of Therapy 12/2021
1	Immunomodulation 01/2021
1	Radiotherapy 05/2014